Stockreport

Nymox Reports Pre-NDA CMC Meeting with the FDA

Nymox Pharmaceutical Corporation  (NYMX) 
US:NASDAQ Investor Relations: nymox.com/default.action?itemid=3
PDF HASBROUCK HEIGHTS, N.J., April 16, 2019 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced that it has held its pre-New Drug Applicati [Read more]